E-64-c
CAS: 76684-89-4
Ref. 3D-FE29622
1mg | A consultar | ||
2mg | A consultar | ||
5mg | A consultar | ||
10mg | A consultar | ||
25mg | A consultar |
Informação sobre produto
- (+)-(2S,3S)-3-((S)-3-Methyl-1-(3-methylbutylcarbamoyl)butylcarbamoyl)-2-oxiranecarboxylic acid
- (2S,3S)-3-({(2S)-4-methyl-1-[(3-methylbutyl)amino]-1-oxopentan-2-yl}carbamoyl)oxirane-2-carboxylic acid
- (2S,3S)-3-[[[(1S)-3-Methyl-1-[[(3-methylbutyl)amino]carbonyl]butyl]amino]carbonyl]-2-oxiranecarboxylic acid
- 2-Oxiranecarboxylic acid, 3-[[[(1S)-3-methyl-1-[[(3-methylbutyl)amino]carbonyl]butyl]amino]carbonyl]-, (2S,3S)-
- Brn 6688621
- E 64c
- EP 475 (Enzyme inhibitor)
- Ep 475
- Loxistatin acid
- NSC 694279
- Ver mais sinónimos
- Oxiranecarboxylic acid, 3-(((3-methyl-1-(((3-methylbutyl)amino)carbonyl)butyl)amino)carbonyl)-, (2S-(2-alpha,3-beta(R*)))-
- Oxiranecarboxylic acid, 3-(((3-methyl-1-(((3-methylbutyl)amino)carbonyl)butyl)amino)carbonyl)-, (2S-(2alpha,3beta(R*)))-
- Oxiranecarboxylic acid, 3-[[[(1S)-3-methyl-1-[[(3-methylbutyl)amino]carbonyl]butyl]amino]carbonyl]-, (2S,3S)-
- Oxiranecarboxylic acid, 3-[[[3-methyl-1-[[(3-methylbutyl)amino]carbonyl]butyl]amino]carbonyl]-, [2S-[2α,3β(R*)]]-
E-64-c is a potent proteolytic enzyme that is used in the treatment of breast cancer. E-64-c cleaves peptide hormones and bcr-abl kinase, which are involved in the development of cancer cells. It can also be used to inhibit the activity of other enzymes, such as phospholipase A2 and cyclooxygenase. The mechanism behind its action is not known, but it may be due to chemical inhibition or reversible denaturation. Chemotherapy drugs that are used to treat breast cancer include doxorubicin, daunorubicin, epirubicin, idarubicin, mitoxantrone, and vincristine.
Propriedades químicas
Consulta técnica sobre: 3D-FE29622 E-64-c
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.